Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT01752751
Official study title

Predicting Tolerance to Radiation Therapy in Older Adults With Cancer

Study summary

A comprehensive geriatric assessment tool developed by Hurria and colleagues has been used in non-radiation oncology clinical settings to predict how older adults tolerate cancer treatments. The investigators think this same tool (referred to as the CGA) can be used in a radiation oncology clinic to predict for poor treatment tolerance.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forPre-treatment Loss of Independent Activities of Daily Living

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 4, 2018 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?UNC Lineberger Comprehensive Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
UNC Lineberger Comprehensive Cancer Center
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Radiation therapy→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • ≥Age 65 years (no upper age limit)
  • Diagnosis of either head and neck cancer, or lung cancer with either radiotherapy or chemoradiotherapy planned as part of standard treatment.
  • Consented for receipt of External Beam Radiation Therapy (EBRT) at UNC Chapel Hill
  • Able to read English (required for CGA)
  • Curative treatment intent as defined by their radiation oncologist Signed, IRB-approved written informed consent
  • Patients enrolled in other CGA studies will not be excluded (see LCCC 0916, 1208)
Reasons someone may not be able to joinExclusion criteria
  • ≥Age 65 years (no upper age limit)
  • Diagnosis of either head and neck cancer, or lung cancer with either radiotherapy or chemoradiotherapy planned as part of standard treatment.
  • Consented for receipt of EBRT at UNC Chapel Hill
  • Able to read English (required for CGA)
  • Curative treatment intent as defined by their radiation oncologist Signed, IRB-approved written informed consent
  • Patients enrolled in other CGA studies will not be excluded (see LCCC 0916, 1208)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Radiation Oncology Clinic - UNC Cancer HospitalChapel Hill, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 4, 2018. Always confirm current availability with the study team.

View original record ↗